Skip to main content
. 2021 Nov 16;9(11):1334. doi: 10.3390/vaccines9111334

Table 1.

Demographic characteristics of the study population according to hRSV detection. Period: 2015–2020.

Demographic Characteristics Total hRSV-Positive
Overall hRSV A hRSV B hRSV A + B
Study population [n (%)] 9584 772 (8.1) 359 (46.5) 395 (51.2) 18 (2.3)
Sex [n (%)]
Female 4673 380 (8.1) 178 (46.8) 193 (50.8) 9 (2.4)
Male 4911 392 (8.0) 181 (46.2) 202 (51.5) 9 (2.3)
Age [years; median (IQR)] 10 (41) 3 (8) 3 (5) * 4 (11) * 3 (3)
Age-group [years; n (%)], n = 9558
≤11 months 232 44 (19.0) 25 (56.8) 19 (43.2) 0
12–23 months 561 107 (19.1) 54 (50.5) 51 (47.6) 2 (1.9)
2–4 1816 319 (17.6) 160 (50.2) 149 (46.7) 10 (3.1)
5–10 2258 120 (5.3) 51 (42.5) 63 (52.5) 6 (5.0)
11–18 964 31 (3.2) 15 (48.4) 16 (51.6) 0
19–34 722 21 (2.9) 12 (57.1) 9 (42.9) 0
35–49 888 23 (2.6) 8 (34.8) 15 (65.2) 0
50–64 1064 51 (4.8) 18 (35.3) 33 (64.7) 0
≥65 1053 54 (5.1) 16 (29.6) 38 (70.4) 0
Healthcare setting [n (%)]
Community-based 8123 713 (8.8) ** 341 (47.8) 354 (49.7) 18 (2.5)
Hospital-based 1461 59 (4.0) ** 18 (30.5) 41 (69.5) 0
non-ICU wards 1026 45 (4.4) 15 (33.3) 30 (66.7) 0
ICU 435 14 (3.2) 3 (21.4) 11 (78.6) 0

IQR = interquartile range, ICU = Intensive Care Unit. * p < 0.001, Wilcoxon rank-sum test. ** p-value < 0.001, Pearson’s chisquare test.